Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Gradient Denervation Technologies develops a medical device for a transvascular treatment of pulmonary hypertension.
EnginZyme is a biotechnology company that creates biomanufacturing techniques for the sustainable production of common goods.
Sitryx is a biopharmaceutical company develops disease modifying therapeutics in immuno-oncology and immuno-inflammation.
Genespire is a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases.
Aledia develops and manufactures innovative light-emitting diodes (LEDs) based on a unique 3D architecture.
HAYA Therapeutics is a biotechnology company developing precision RNA-guided medicines that target the dark genome.
CinCor is a clinical-stage biopharmaceutical company that develops treatments for cardiovascular diseases.
Biosyntia is a biotech startup within synthetic biology and metabolic engineering.
Protera is a biotechnology company that produce protein-based food ingredients.
Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease.
Inspirna is a biotechnology company developing drugs for the treatment of cancer.
Mozart is a biotech startup focusing on the development of disease-modifying therapies for autoimmune and inflammatory diseases.
We provide simple, sophisticated respiratory solutions for post-ICU and home environments, eliminating unnecessary cost and complexity.
Ingenix is building an AI Co-pilot for generating real-time hypotheses on clinical endpoints values and adverse events.
ProQR Therapeutics is a biotech company focused on developments of drugs to treat genetic disorders.
TISSIUM develops biodegradable sealants and adhesives for wound closure in the field of minimally-invasive surgery.
Inventiva Pharma is a biopharmaceutical company with several drug candidates at clinical and preclinical stage.
Bionyra Pharma is a clinical-stage biopharmaceutical startup developing next-generation biologics for severe immune-mediated inflammation.
CorWave is a medical device company developing innovative heart pumps.
One Biosciences leverages single-cell technologies to identify new therapeutics for difficult-to-treat diseases.
Biotalys is an AgTech company that employs its proprietary AGROBODY™ technology platform to develop crop protection products.
Signadori Bio is the next-generation cellular immunotherapy for cancer cure.
Abivax develops medicines that alter the body's natural immune system mechanisms.
P2 Science produces bio-based chemicals from renewable materials for consumer and industrial use.
Sofinnova Partners has invested in 148 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Sofinnova Partners's top investment sectors include Biotechnology, Health Care, Therapeutics, Manufacturing, Medical Device. The firm invests across 22 different industry categories.
Among tracked funding rounds, CinCor Pharma received $225.0M in a Post-IPO Equity round. Sofinnova Partners's total known invested capital is $4.9B.
Sofinnova Partners's average investment size is $39.9M across its portfolio of 148 companies.
Recent Sofinnova Partners portfolio additions include Gradient Denervation Technologies, EnginZyme, Sitryx Therapeutics, Genespire, Aledia. These companies were founded in 2020 or later.